Market revenue in 2021 | USD 1,791.7 million |
Market revenue in 2028 | USD 2,135.4 million |
Growth rate | 2.5% (CAGR from 2021 to 2028) |
Largest segment | Pcr-based amplification |
Fastest growing segment | Loop Mediated Isothermal Amplification (LAMP) |
Historical data | 2018 - 2020 |
Base year | 2021 |
Forecast period | 2022 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | PCR-based Amplification, Loop Mediated Isothermal Amplification (LAMP), Nucleic Acid Sequence Based Amplification (NASBA), Strand Displacement Amplification (SDA), Multiple displacement amplification (MDA), Rolling Circle Amplification (RCA), Ramification amplification method (RAM) |
Key market players worldwide | Qiagen NV, Illumina Inc, Bio-Rad Laboratories Inc, Silicon Laboratories Inc, Merck KGaA, Promega, Takara Bio Inc, Danaher Corp, New England Biolabs, 4Basebio, LGC Group, Vazyme Biotech, MyBiosource |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to gene amplification technologies market will help companies and investors design strategic landscapes.
Pcr-based amplification was the largest segment with a revenue share of 90.63% in 2021. Horizon Databook has segmented the China gene amplification technologies market based on pcr-based amplification, loop mediated isothermal amplification (lamp), nucleic acid sequence based amplification (nasba), strand displacement amplification (sda), multiple displacement amplification (mda), rolling circle amplification (rca), ramification amplification method (ram) covering the revenue growth of each sub-segment from 2018 to 2028.
China is recognized as one of the major contributors to Asia Pacific's revenue generation. The presence of several academic and research institutes and the growing penetration of global companies in China's marketplace are the primary driving forces for the country's market growth.
In August 2020, researchers from Huazhong University of Science and Technology, China published a research study discussed the values and challenges associated with COVID-19 detection tests based on nucleic acid amplification technology.
Furthermore, in January 2019 researchers from Qingdao Municipal Center for Disease Control and Prevention along with Beijing Pediatric Research Institute published a study that evaluated the feasibility and performance of loop-mediated isothermal amplification (LAMP) in the diagnosis of pulmonary tuberculosis.
Horizon Databook provides a detailed overview of country-level data and insights on the China gene amplification technologies market , including forecasts for subscribers. This country databook contains high-level insights into China gene amplification technologies market from 2018 to 2028, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account